Cardiovascular disease (CVD) is a multifactorial disorder that involves both environmental and genetic factors;however, individual CVD susceptibility in this regard is not clearly understood. Recent studies on CVD susceptibility and resistance support the concept of groups of genes being involved in disease susceptibility - and while this is important in understanding that gene "groups" may be involved in influencing individual biological responses to an environmental challenge, they do not address the underlying issue of why these differences exist, nor how they might have developed. In this respect, current studies have not seriously considered the role of the mitochondrial DNA (mtDNA) and prehistoric selection factors that may have influenced mtDNA genetic selection, which today, potentially influence individual susceptibility to disease development. This proposal tests the hypothesis that mitochondrial genetic background significantly influences CVD susceptibility by determining the impact of different mitochondrial genetic backgrounds on nuclear gene expression and disease development in both human and animal models of CVD. Preliminary studies are provided that show mtDNA background significantly influences: i) mitochondrial function;ii) vascular function;iii) atherogenic susceptibility;iv) nuclear gene expression;and, v) can be associated with CVD incidence in humans. Studies are also presented that show distinct metabolic and oxidative capacities in human endothelial cells harboring either African or Caucasian mtDNA backgrounds. It is predicted that under normal physiological conditions these differences appear to have no functional outcome, but under stress (e.g. exposure to cytokines), their responses significantly differ with the cells harboring the African mtDNAs being more susceptible to uncontrolled ROS production and mitochondrial damage. Consequently, it is hypothesized that: Mitochondrial genetics and function are important factors in influencing individual CVD susceptibility. The studies herein represent a first step towards determining the potential role of mitochondrial genetics and function as a significant factor in modulating nuclear gene expression, and hence, in regulating individual biological responses to environmental and behavioral stimuli that may contribute to disease susceptibility. The proposed studies are novel in that they present a "paradigm shift" in the understanding of the role of the mitochondrion in disease risk and development.

Public Health Relevance

Cardiovascular disease (CVD) is a multifactorial disorder that involves both environmental and genetic factors, however, individual CVD susceptibility in this regard is not clearly understood. The current proposal investigates the role of the mitochondrial DNA in influencing CVD development by determining the impact of different mitochondrial genetic backgrounds on nuclear gene expression and disease development. The studies herein represent a first step towards determining the potential role of mitochondrial genetics and function as a significant factor in modulating nuclear gene expression, and hence, in regulating individual biological responses to environmental and behavioral stimuli that may contribute to disease susceptibility.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL103859-04
Application #
8657095
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Galis, Zorina S
Project Start
2011-07-19
Project End
2015-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
4
Fiscal Year
2014
Total Cost
$485,663
Indirect Cost
$96,336
Name
University of Alabama Birmingham
Department
Pathology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Betancourt, Angela M; King, Adrienne L; Fetterman, Jessica L et al. (2014) Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice. Biochem J 461:223-32
Dunham-Snary, Kimberly J; Sandel, Michael W; Westbrook, David G et al. (2014) A method for assessing mitochondrial bioenergetics in whole white adipose tissues. Redox Biol 2:656-60
Ballinger, Scott W (2013) Beyond retrograde and anterograde signalling: mitochondrial-nuclear interactions as a means for evolutionary adaptation and contemporary disease susceptibility. Biochem Soc Trans 41:111-7
Mitchell, Tanecia; Chacko, Balu; Ballinger, Scott W et al. (2013) Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics. Biochem Soc Trans 41:127-33
Chacko, Balu K; Kramer, Philip A; Ravi, Saranya et al. (2013) Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab Invest 93:690-700
Dunham-Snary, Kimberly J; Ballinger, Scott W (2013) Mitochondrial genetics and obesity: evolutionary adaptation and contemporary disease susceptibility. Free Radic Biol Med 65:1229-37
Fetterman, Jessica L; Zelickson, Blake R; Johnson, Larry W et al. (2013) Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochem J 455:157-67